Upgrade to SI Premium - Free Trial

Pulse Biosciences, Inc. (PLSE)

55.20 +0.99 (1.83%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/16/26)

Latest Headlines

Pulse Biosciences sets up $85M at-the-market stock offering September 15, 2026 4:46 PM - StreetInsider Form 8-K PULSE BIOSCIENCES, INC. For: Sep 14 September 15, 2026 4:44 PM - SEC Filing Form 424B5 PULSE BIOSCIENCES, INC. September 15, 2026 4:44 PM - SEC Filing Form 8-K PULSE BIOSCIENCES, INC. For: Sep 15 September 15, 2026 8:55 AM - SEC Filing Pulse Biosciences completes 100-patient thyroid nodule study enrollment September 15, 2026 7:01 AM - StreetInsider Pulse Biosciences Completes Enrollment in the PRECISE-BTN Clinical Study Evaluating the nPulse™ Vybrance™ Percutaneous Electrode System for Symptomatic Benign Thyroid Nodules September 15, 2026 7:00 AM - BizWire Freedom Capital Starts Pulse Biosciences (PLSE) at Buy September 9, 2026 6:14 AM - StreetInsider Form 4 PULSE BIOSCIENCES, INC. For: Aug 26 Filed by: Teplitsky Liane Rae August 28, 2026 7:49 PM - SEC Filing Form 4 PULSE BIOSCIENCES, INC. For: Apr 08 Filed by: Teplitsky Liane Rae August 28, 2026 7:45 PM - SEC Filing Form 3 PULSE BIOSCIENCES, INC. For: Apr 08 Filed by: Teplitsky Liane Rae August 28, 2026 7:42 PM - SEC Filing Form 4 PULSE BIOSCIENCES, INC. For: Feb 03 Filed by: Skinner Jon August 28, 2026 7:17 PM - SEC Filing Form 3 PULSE BIOSCIENCES, INC. For: Feb 03 Filed by: Skinner Jon August 28, 2026 7:15 PM - SEC Filing Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 18, 2026 7:00 AM - BizWire Needham Starts Pulse Biosciences (PLSE) at Buy August 17, 2026 6:34 AM - StreetInsider Pulse Biosciences (PLSE) PT Raised to $45 at Mizuho August 10, 2026 7:13 AM - StreetInsider Pulse Biosciences (PLSE) PT Raised to $43 at Canaccord August 10, 2026 7:00 AM - StreetInsider Form 8-K PULSE BIOSCIENCES, INC. For: Aug 06 August 6, 2026 5:05 PM - SEC Filing Form 424B5 PULSE BIOSCIENCES, INC. August 6, 2026 5:04 PM - SEC Filing Pulse Biosciences, Inc. (PLSE) Misses Q2 EPS by 8c August 6, 2026 4:57 PM - StreetInsider Form 10-Q PULSE BIOSCIENCES, INC. For: Jun 30 August 6, 2026 4:32 PM - SEC Filing Form 8-K PULSE BIOSCIENCES, INC. For: Aug 06 August 6, 2026 4:09 PM - SEC Filing Pulse Biosciences Reports Business Updates and Second Quarter 2026 Financial Results August 6, 2026 4:05 PM - BizWire Pulse Biosciences to Present at Canaccord Genuity’s 46th Annual Growth Conference July 30, 2026 4:05 PM - BizWire Form 8-K PULSE BIOSCIENCES, INC. For: Jul 29 July 29, 2026 9:02 AM - SEC Filing Pulse Biosciences passes enrollment midpoint in atrial fibrillation study July 29, 2026 7:01 AM - StreetInsider Pulse Biosciences Surpasses Enrollment Midpoint in NANOPULSE-AF IDE Pivotal Study July 29, 2026 7:00 AM - BizWire Pulse Biosciences (PLSE) PT Raised to $35 at Oppenheimer July 28, 2026 6:04 AM - StreetInsider Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026 July 21, 2026 4:05 PM - BizWire Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 15, 2026 4:05 PM - BizWire Full Article List